The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
Open accessAbstract
Modified anti-CD3 mAbs are emerging as a possible means of inducing immunologic tolerance in settings including transplantation and autoimmunity such as in type 1 diabetes. In a trial of a modified anti-CD3 mAb [hOKT3gamma1(Ala-Ala)] in patients with type 1 diabetes, we identified clinical responders by an increase in the number of peripheral blood CD8+ cells following treatment with the mAb. Here we show that the anti-CD3 mAb caused activation of CD8+ T cells that was similar in vitro and in vivo and induced regulatory CD8+CD25+ T cells. These cells inhibited the responses of CD4+ cells to the mAb itself and to antigen. The regulatory CD8+CD25+ cells were CTLA4 and Foxp3 and required contact for inhibition. Foxp3 was also induced on CD8+ T cells in patients during mAb treatment, which suggests a potential mechanism of the anti-CD3 mAb immune modulatory effects involving induction of a subset of regulatory CD8+ T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“Murine studies (22, 35, 36) have shown that Foxp3 was expressed specifically in CD4+CD25+ T cells, was not expressed in CD4+CD25– or CD8+ T cells, and was responsible for the suppressor activity of the CD4+CD25+ cells, because introduction of Foxp3 into CD4+CD25– cells by retroviral vector was shown to induce regulato…”
BackgroundThe Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Self-citationWildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Self-citationInduction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Self-citationHori, S., Nomura, T., & Sakaguchi, S. (2017) · The Journal of Immunology · doi:10.1093/jimmunol/198.3.981 · Cited by 1,066
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 800
In Vivo Instruction of Suppressor Commitment in Naive T Cells
Apostolou, I., & von Boehmer, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040249 · Cited by 728
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Self-citationNakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., & Strober, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.834 · Cited by 630
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Self-citationDieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., & Schuler, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020642 · Cited by 467
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
Morgan, M. E., van Bilsen, J. H. M., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G., van der Zanden, L., de Vries, R. R. P., Huizinga, T. W. J., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.05.016 · Cited by 418
Regulatory T cells under scrutiny
François Bach, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1026 · Cited by 413
Cutting Edge: CD4 and CD8 T Cells Are Intrinsically Different in Their Proliferative Responses
Foulds, K. E., Zenewicz, L. A., Shedlock, D. J., Jiang, J., Troy, A. E., & Shen, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1528 · Cited by 385
Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1320 · Cited by 383
Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes
Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., & Romagnani, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020110 · Cited by 379
Hering, B. J., Kandaswamy, R., Harmon, J. V., Ansite, J. D., Clemmings, S. M., Sakai, T., Paraskevas, S., Eckman, P. M., Sageshima, J., Nakano, M., et al. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00351.x · Cited by 367
Self-citationReversal of in vitro T cell clonal anergy by IL-2 stimulation
Beverly, B., Kang, S.-M., Lenardo, M. J., & Schwartz, R. H. (1992) · International Immunology · doi:10.1093/intimm/4.6.661 · Cited by 333
Stephens, L. A., & Mason, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3105 · Cited by 311
Foxp3 and Natural Regulatory T Cells
Ramsdell, F. (2003) · Immunity · doi:10.1016/s1074-7613(03)00207-3 · Cited by 275
Suppressor T cells – they’re back and critical for regulation of autoimmunity!
Chatenoud, L., Salomon, B., & Bluestone, J. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820112.x · Cited by 273
Self-citationIn Vitro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies
Xu, D., Alegre, M.-L., Varga, S. S., Rothermel, A. L., Collins, A. M., Pulito, V. L., Hanna, L. S., Dolan, K. P., Parren, P. W. H. I., Bluestone, J. A., et al. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1617 · Cited by 238
Self-citationThe origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery
Sakaguchi, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320274 · Cited by 219
Bolt, S., Routledge, E., Lloyd, I., Chatenoud, L., Pope, H., Gorman, S. D., Clark, M., & Waldmann, H. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230216 · Cited by 218
Smith, J. A., Tso, J. Y., Clark, M. R., Cole, M. S., & Bluestone, J. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1413 · Cited by 192
Self-citationWoodle, E. S., Xu, D., Zivin, R. A., Auger, J., Charette, J., O'Laughlin, R., Peace, D., Jolliffe, L. K., Haverty, T., Bluestone, J. A., et al. (1999) · Transplantation · doi:10.1097/00007890-199909150-00003 · Cited by 188
Self-citationIL-10 and TGF- induce alloreactive CD4+CD25- T cells to acquire regulatory cell function
Chen, Z.-M. (2003) · Blood · doi:10.1182/blood-2002-09-2798 · Cited by 183
Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
Herold, K. C., Burton, J. B., Francois, F., Poumian-Ruiz, E., Glandt, M., & Bluestone, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16090 · Cited by 177
Self-citationCosmi, L., Liotta, F., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Lasagni, L., Vanini, V., Romagnani, P., Maggi, E., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3302 · Cited by 167
Filaci, G., Fravega, M., Negrini, S., Procopio, F., Fenoglio, D., Rizzi, M., Brenci, S., Contini, P., Olive, D., Ghio, M., et al. (2004) · Human Immunology · doi:10.1016/j.humimm.2003.12.001 · Cited by 163 · cited 1×
“An antigen-nonspecific CD8+ suppressor population has also been described that inhibits T cell proliferation and CTL function (51).”
BackgroundJiang, H., & Chess, L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.185 · Cited by 158
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
Utset, T. O., Auger, J., Peace, D., Zivin, R. A., Xu, D., Jolliffe, L. K., Alegre, M., Bluestone, J. A., & Clark, M. R. (2002) · PubMed · Cited by 142
Self-citationCobbold, S. P., Nolan, K. F., Graça, L., Castejón, R., Moine, A. L., Frewin, M. R., Humm, S., Adams, E., Thompson, S. A. J., Zélénika, D., et al. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00078.x · Cited by 134
Status of Activation of Circulating Vaccine-Elicited CD8+ T Cells
Nielsen, M.-B., Monsurrò, V., Migueles, S. A., Wang, E., Pérez‐Díez, A., Lee, K.-H., Kammula, U. S., Rosenberg, S. A., & Marincola, F. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2287 · Cited by 112
Induction of TCR Vβ-Specific CD8+ CTLs by TCR Vβ-Derived Peptides Bound to HLA-E
Li, J., Goldstein, I., Glickman-Nir, E., Jiang, H., & Chess, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3800 · Cited by 84
Ware, R., Jiang, H., Braunstein, N. S., Kent, J. R., Wiener, E., Pernis, B., & Chess, L. (1995) · Immunity · doi:10.1016/s1074-7613(95)80066-2 · Cited by 63
Type 1 T Regulatory Cells and Their Relationship with CD4 + CD25 + T Regulatory Cells
Roncarolo, M. G., Gregori, S., & Levings, M. K. (2003) · Novartis Foundation symposium · doi:10.1002/0470871628.ch9 · Cited by 53
O'Garra, A., & Barrat, F. J. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00239-0 · Cited by 42 · cited 2×
“CD4 + cells, some of which express CD25, regulate T cell responses through cell contact– dependent mechanisms as well as production of soluble mediators including IL-10 and TGF-β (15, 17–19, 40, 41).”
The puzzling world of murine T regulatory cells
Battaglia, M., Blazar, B. R., & Roncarolo, M. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01573-3 · Cited by 31
Marshall, D. R., Olivas, E., Andreansky, S. S., Gruta, N. L. L., Neale, G. A. M., Gutierrez, A., Wichlan, D., Wingo, S., Cheng, C., Doherty, P. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501960102 · Cited by 29
CD8+CD28− T suppressor cells represent a distinct subset in a heterogeneous population
Colovai, A. I., Ciubotariu, R., Liu, Z., Cortesini, R., & Suciu‐Foca, N. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01927-8 · Cited by 19
Carpenter, P. A., Tso, J. Y., Press, O. W., Yu, X., & Anasetti, C. (2000) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01343-9 · Cited by 6
Cited by
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Self-citationNormalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Self-citationCancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
Kudo-Saito, C., Shirako, H., Takeuchi, T., & Kawakami, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.023 · Cited by 870
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Metadata
- Authors
- Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-10-01
- Volume
- 115
- Issue
- 10
- Pages
- 2904-2913
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2156694159
- Cited by
- 339
- References
- 51
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.